Monashee Scales Back Structure: GPCR Bet Reassessed
A major hedge fund slashed its stake in Structure Therapeutics, prompting questions about the future path for GPCR-fo...
Using Index Level to adjust risk lets you scale exposure in line with market momentum, maintaining a balanced, rules-based approach.
27,393 articlesA major hedge fund slashed its stake in Structure Therapeutics, prompting questions about the future path for GPCR-fo...
This week’s rally in First Solar stock is turning heads. We break down the catalysts, assess risks, and offer practic...
Investors eye AGNC for a high yield, but sustainability is key. This analysis breaks down how AGNC funds its dividend...
Kalshi is courting a lofty valuation after a recent funding round, signaling confidence in prediction markets amid a ...
As data centers expand and AI workloads surge, the tech industry faces a critical power reliability challenge. This a...
A high-profile fund sold a sizable GRAIL stake right before a dramatic 50% one-day drop. This article unpacks the mov...
A fund’s big move out of a top-performing pharma stock can puzzle investors. Here’s a clear, practical look at what k...
A major biotech fund boosted its Erasca stake after a monumental rise. This article unpacks the logic, risks, and tak...
Geopolitical shocks echoed through crypto flows as Iranian exchanges saw a dramatic outflow spike totaling $10.3 mill...
Washington moves to outlaw noncompete agreements statewide, imposing a 2027 deadline. The sweeping policy reshapes hi...
A wave of state laws on private listings in housing is reshaping how loans and mortgages are marketed. Three regulato...
Behind the glamorous photos lies a blueprint for smarter money habits. This article connects Nicola Peltz shows balle...